Aratana Therapeutics to Present at the Leerink Global Healthcare Conference

Feb 06, 2015, 16:00 ET from Aratana Therapeutics, Inc.

KANSAS CITY, Kan., Feb. 6, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today announced that it will present at the Leerink Global Healthcare Conference to be held February 11-12, 2015, at the Waldorf Astoria Hotel in New York. 

Steven St. Peter, M.D., President and Chief Executive Officer of Aratana Therapeutics, will provide an overview of the Company's business during an analyst-led fireside chat and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.


Leerink Global Healthcare Conference


Wednesday, February 11, 2015


3:55 pm (Eastern Time) 


The Waldorf Astoria

The presentations will be webcast live and remain available for 30 days following the presentation.  To access the webcasts, please visit the investor relations section of the Aratana website at

About Aratana Therapeutics Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The company's pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit

Contacts: For investor inquires: Aratana Therapeutics, Inc. Craig Tooman; (913) 353-1026 For media inquiries: Tiberend Strategic Advisors, Inc. Andrew Mielach; (212) 375-2694


SOURCE Aratana Therapeutics, Inc.